Stelexis Therapeutics stelexis.com


Public lists: Cancer Therapeutics (1146)

Stelexis is a cancer therapeutics company, utilizing its proprietary platform to selectively target pre-cancerous stem cells to discover and develop therapies. Its proprietary drug discovery platform identifies the earliest definable pre-cancerous stem and progenitor cells that lead to the formation of human primary and recurrent tumors for therapeutic intervention and relapse prevention.

Stelexis is a cancer therapeutics company, utilizing its proprietary platform to selectively target pre-cancerous stem cells to discover and develop therapies. Its proprietary drug discovery platform identifies the earliest definable pre-cancerous st...Show all

Company (Alive / Active)

Phone:

Fax:

780 Third Avenue

New York, 10017
New York, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Stelexis Therapeutics $43M Jan 7, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Stelexis Therapeutics Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
Undisclosed InvestorsOtherSeries A
See all 1 investors
There is no Board of Directors data available for this company. Please select another tab.
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)